Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $122.17M.
ENTERPRISE VALUE (EV)
$122.17M
Atara Biotherapeutics, Inc.
Market Cap
$87.20M
Enterprise Value (EV)
$122.17M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $87.20M | $122.17M |
| CareCloud, Inc. (CCLD)vs › | $86.90M | $127.52M |
| ImmuCell Corporation (ICCC)vs › | $88.48M | $92.07M |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.78M | $51.28M |
| Rallybio Corporation (RLYB)vs › | $89.38M | N/A |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.44M | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.60M | $77.35M |
| Humacyte, Inc. (HUMA)vs › | $84.07M | $70.34M |
| electroCore, Inc. (ECOR)vs › | $90.16M | $91.22M |
| ProMIS Neurosciences, Inc. (PMN)vs › | $83.53M | $30.10M |
Market Cap
$87.20M
Total Debt
$43.45M
Cash
$8.48M
Enterprise Value
$122.17M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
